Timothy P Coughlin - Net Worth and Insider Trading
Timothy P Coughlin Net Worth
The estimated net worth of Timothy P Coughlin is at least $20 Million dollars as of 2024-04-24. Timothy P Coughlin is the CFO of Neurocrine Biosciences Inc and owns about 137,961 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $19 Million. Timothy P Coughlin is also the Director of Fate Therapeutics Inc and owns about 57,632 shares of Fate Therapeutics Inc (FATE) stock worth over $261,649. Details can be seen in Timothy P Coughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy P Coughlin has not made any transactions after 2022-06-03 and currently still holds the listed stock(s).
Transaction Summary of Timothy P Coughlin
Timothy P Coughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy P Coughlin owns 4 companies in total, including Travere Therapeutics Inc (TVTX) , aTyr Pharma Inc (LIFE) , and Fate Therapeutics Inc (FATE) among others .
Click here to see the complete history of Timothy P Coughlin’s form 4 insider trades.
Insider Ownership Summary of Timothy P Coughlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2015-03-31 | director |
| LIFE | aTyr Pharma Inc | 2017-04-07 | director |
| FATE | Fate Therapeutics Inc | 2022-06-03 | director |
| NBIX | Neurocrine Biosciences Inc | 2017-02-06 | VP and Chief Financial Officer |
Timothy P Coughlin Latest Holdings Summary
Timothy P Coughlin currently owns a total of 2 stocks. Among these stocks, Timothy P Coughlin owns 137,961 shares of Neurocrine Biosciences Inc (NBIX) as of February 6, 2017, with a value of $19 Million and a weighting of 98.67%. Timothy P Coughlin also owns 57,632 shares of Fate Therapeutics Inc (FATE) as of June 3, 2022, with a value of $261,649 and a weighting of 1.33%.
Latest Holdings of Timothy P Coughlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2017-02-06 | 137,961 | 140.25 | 19,349,030 |
| FATE | Fate Therapeutics Inc | 2022-06-03 | 57,632 | 4.54 | 261,649 |
Holding Weightings of Timothy P Coughlin
Timothy P Coughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 963 shares on February 6, 2017, which brought Timothy P Coughlin around $41,544.
According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 1 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 1,439 shares on June 3, 2022, which brought Timothy P Coughlin around $32,824.
Insider Trading History of Timothy P Coughlin
- 1
Timothy P Coughlin Trading Performance
GuruFocus tracks the stock performance after each of Timothy P Coughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy P Coughlin is 22.19%. GuruFocus also compares Timothy P Coughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy P Coughlin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy P Coughlin's insider trading performs compared to the benchmark.
Performance of Timothy P Coughlin
Average Return
26.14%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.98 | 22.19 | 10.64 | 26.14 | 94.76 | 63.61 |
| Relative Return to S&P 500(%) | -16.66 | 14.97 | 1.85 | 8.34 | 85.49 | 51.44 |
Timothy P Coughlin Ownership Network
Ownership Network List of Timothy P Coughlin
Ownership Network Relation of Timothy P Coughlin
Timothy P Coughlin Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Timothy P Coughlin is the director of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Financial Officer Christopher R. Cline , director & Chief Executive Officer Eric M Dube , and VP & Corp Controller and CAO Sandra Calvin .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Timothy P Coughlin made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,306 shares made by Christopher R. Cline , a net sale of 32,591 shares made by Eric M Dube , and a net sale of 9,354 shares made by Elizabeth E Reed .
In summary, during the past 3 months, insiders sold 54 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 54 shares. During the past 18 months, 73,182 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 73,182 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Timothy P Coughlin Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy P Coughlin. You might contact Timothy P Coughlin via mailing address: 339 North Granados Ave, Solana Beach Ca 92075.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
